Clinical Trial: Safety and Effectiveness of Mosaic for the Treatment of Midface Volume Deficit

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710443) titled 'Safety and Effectiveness of Mosaic for the Treatment of Midface Volume Deficit' on July 08.

Brief Summary: The goal of this clinical trial is to study whether the Mosaic Injectable Dermal Implant is a safe and effective treatment for age-related midface volume deficit in adults who are at least 22 years of age. The main questions it aims to answer are:

1. What medical problems do participants have when receiving Mosaic over the 12 months following treatment.

2. How much does Mosaic improve the midface volume at 6 months post-treatment.

Participants will:

Receive injections to the midface to correct volume deficit. One month from...